Advaxis (Warrant)

YTD

ALL

Why Robinhood?

You can watch ADXSW and buy or sell other stocks, ETFs, and their options commission-free!

About ADXSW

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia.

CEO

Ken Berlin

CEOKen Berlin

Employees

—

Employees—

Headquarters

Monmouth Junction, New Jersey

HeadquartersMonmouth Junction, New Jersey

Founded

2017

Founded2017

Employees

—

Employees—

ADXSW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

Advaxis (Warrant)(ADXSW) stock is priced at $0.01.

On 2025-12-12, Advaxis (Warrant)(ADXSW) stock opened at —, reached a high of —, and a low of —.

The Advaxis (Warrant)(ADXSW)'s current trading volume is 0.